Journal of Scleroderma and Related Disorders · 2017 · 521 citations · 31 references
MedicineClinical SciencesNeurologyDermatopathologyGenodermatosesRheumatologySkin AssessmentSkin ExaminationSystemic SclerosisClinical Skin ScoringDiffuse Cutaneous Systemic SclerosisOutcome Measure InterpretationOutcome Measure StandardizationScleroderma TreatmentSkin Thickness MeasurementState-of-the-art ReviewSystemic Sclerosis Skin Involvement
The modified Rodnan skin score (mRSS) is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma). This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of mRSS as an outcome measure, provides guidance on assessing mRSS, and makes recommendations for incorporation of the mRSS into clinical trials.
31
Cyclophosphamide versus Placebo in Scleroderma Lung Disease
Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text
Criteria for the classification of early systemic sclerosis.
E. Carwile LeRoy, Thomas A. Medsger · PubMed · 2001 · 1.4K citations